Nomura loses Asia healthcare IB head to biopharma firm
Nomura’s Asia ex-Japan healthcare investment banking head, Vijay Karwal, has left the firm after a three year stint to join a biopharmaceutical company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: